Genetic diversity in fluoroquinolone and macrolide-resistant Campylobacter coli from pigs

被引:17
作者
Keller, J [1 ]
Perreten, V [1 ]
机构
[1] Univ Bern, Inst Vet Bacteriol, CH-3001 Bern, Switzerland
关键词
Campylobacter; fluoroquinolones; macrolides; resistance; genotyping; pigs;
D O I
10.1016/j.vetmic.2005.10.019
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The genetic diversity of 115 Campylobacter coli strains, isolated from pigs of 59 geographical distant farms in Switzerland, were characterized on the basis of their DNA fingerprints and resistance to macrolides and fluoroquinol ones. Sequence analysis showed that the macrolide-resistant isolates had a point mutation in the 23S ribosomal RNA (rRNA) genes (A2075G) and that the fluoroquinolone-resistant isolates had a point mutation in the gyrase gene gyrA (C257T). One fluoroquinolone-resistant strain had an additional transition mutation in the gyrB gene (A1471C). The flaA restriction fragment length polymorphism (RFLP) genotyping revealed that 57% of the isolates were genetically different. Point mutations in the 23S rRNA and gyrA genes could be found in both genetically distant and genetically related isolates. Additionally, isolates with and without point mutations were found within individual farms and on different farms. This study showed that the ciprofloxacin and erythromycin-resistant C. coli population present on the pig farms is not issued from a common ancestral clone, but individual Campylobacter strains have most likely mutated independently to acquire resistances under the selective pressure of an antibiotic. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 28 条
[1]   Banning antimicrobial growth promoters in feedstuffs does not result in increased therapeutic use of antibiotics in medicated feed in pig farming [J].
Arnold, S ;
Gassner, B ;
Giger, T ;
Zwahlen, R .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (05) :323-331
[2]   Single or double mutational alterations of GyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli [J].
Bachoual, R ;
Ouabdesselam, S ;
Mory, F ;
Lascols, C ;
Soussy, CJ ;
Tankovic, J .
MICROBIAL DRUG RESISTANCE, 2001, 7 (03) :257-261
[3]   Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing [J].
Beckmann, L ;
Müller, M ;
Luber, P ;
Schrader, C ;
Bartelt, E ;
Klein, G .
JOURNAL OF APPLIED MICROBIOLOGY, 2004, 96 (05) :1040-1047
[4]   Epidemiologic and clinical features of Campylobacter jejuni infections [J].
Blaser, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 :S103-S105
[5]   Campylobacter, from obscurity to celebrity [J].
Butzler, JP .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (10) :868-876
[6]  
*CLIN LAB STAND I, 2002, M31A2 CLIN LAB STAND
[7]   Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barre or Miller Fisher syndrome [J].
Duim, B ;
Ang, CW ;
van Belkum, A ;
Rigter, A ;
van Leeuwen, NWJ ;
Endtz, HP ;
Wagenaar, JA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (09) :3917-3923
[8]   Quinolone and macrolide resistance in Campylobacter jejuni and C-coli:: Resistance mechanisms and trends in human isolates [J].
Engberg, J ;
Aarestrup, FM ;
Taylor, DE ;
Gerner-Smidt, P ;
Nachamkin, I .
EMERGING INFECTIOUS DISEASES, 2001, 7 (01) :24-34
[9]   Risk factors for sporadic Campylobacter infection in the United States:: A case-control study in FoodNet sites [J].
Friedman, CR ;
Hoekstra, RM ;
Samuel, M ;
Marcus, R ;
Bender, J ;
Shiferaw, B ;
Reddy, S ;
Ahuja, SD ;
Helfrick, DL ;
Hardnett, F ;
Carter, M ;
Anderson, B ;
Tauxe, RV .
CLINICAL INFECTIOUS DISEASES, 2004, 38 :S285-S296
[10]   Macrolide resistance in Campylobacter jejuni and Campylobacter coli:: Molecular mechanism and stability of the resistance phenotype [J].
Gibreel, A ;
Kos, VN ;
Keelan, M ;
Trieber, CA ;
Levesque, S ;
Michaud, S ;
Taylor, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2753-2759